FI991477L - Menetelmä tolterodiinin valmistamiseksi - Google Patents
Menetelmä tolterodiinin valmistamiseksi Download PDFInfo
- Publication number
- FI991477L FI991477L FI991477A FI991477A FI991477L FI 991477 L FI991477 L FI 991477L FI 991477 A FI991477 A FI 991477A FI 991477 A FI991477 A FI 991477A FI 991477 L FI991477 L FI 991477L
- Authority
- FI
- Finland
- Prior art keywords
- preparing tolterodine
- tolterodine
- preparing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
- C07D311/20—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 hydrogenated in the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C213/02—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions involving the formation of amino groups from compounds containing hydroxy groups or etherified or esterified hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C215/48—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups
- C07C215/54—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- Pyrane Compounds (AREA)
- Saccharide Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Optical Integrated Circuits (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3396196P | 1996-12-31 | 1996-12-31 | |
| PCT/US1997/022521 WO1998029402A1 (en) | 1996-12-31 | 1997-12-18 | Process to prepare tolterodine |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI991477A7 FI991477A7 (fi) | 1999-06-29 |
| FI991477L true FI991477L (fi) | 1999-06-29 |
| FI991477A0 FI991477A0 (fi) | 1999-06-29 |
Family
ID=21873473
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI991477A FI991477A0 (fi) | 1996-12-31 | 1997-12-18 | Menetelmä tolterodiinin valmistamiseksi |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US5922914A (de) |
| EP (1) | EP0960109B1 (de) |
| JP (1) | JP4199310B2 (de) |
| KR (2) | KR20000057548A (de) |
| CN (1) | CN1151141C (de) |
| AT (1) | ATE226949T1 (de) |
| AU (1) | AU717985B2 (de) |
| CA (1) | CA2273789C (de) |
| CZ (1) | CZ295477B6 (de) |
| DE (1) | DE69716767T2 (de) |
| DK (1) | DK0960109T3 (de) |
| ES (1) | ES2186018T3 (de) |
| FI (1) | FI991477A0 (de) |
| HU (1) | HUP0000527A3 (de) |
| NO (1) | NO317158B1 (de) |
| NZ (1) | NZ336533A (de) |
| PL (1) | PL191603B1 (de) |
| PT (1) | PT960109E (de) |
| RU (1) | RU2176246C2 (de) |
| SI (1) | SI0960109T1 (de) |
| SK (1) | SK283591B6 (de) |
| WO (1) | WO1998029402A1 (de) |
Families Citing this family (59)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2259012C (en) * | 1996-07-19 | 2008-05-13 | Gunnar Aberg | S(-)-tolterodine in the treatment of urinary and gastrointestinal disorders |
| EP0957073A1 (de) * | 1998-05-12 | 1999-11-17 | Schwarz Pharma Ag | 3,3-Diphenylpropylaminderivate |
| ES2246488T3 (es) * | 1999-07-01 | 2006-02-16 | PHARMACIA & UPJOHN COMPANY LLC | Reboxetina para tratar la migraña. |
| SE9904850D0 (sv) * | 1999-12-30 | 1999-12-30 | Pharmacia & Upjohn Ab | Novel process and intermediates |
| US6566537B2 (en) | 1999-12-30 | 2003-05-20 | Pharmacia Ab | Process and intermediates |
| DE10028443C1 (de) * | 2000-06-14 | 2002-05-29 | Sanol Arznei Schwarz Gmbh | Verfahren zur Herstellung von 3,3-Diarylpropylaminen, (R,S)- und (R)-4-Phenyl-2-chromanon-6-carbonsäure sowie (R)-4-Phenyl-2-chromanon-carbonsäure-cinchonidinsalz und deren Verwendung zur Herstellung eines rechtsdrehenden Hydroxybenzylalkohols und von pharmazeutischen Zusammensetzungen |
| DE10033016A1 (de) * | 2000-07-07 | 2002-01-24 | Sanol Arznei Schwarz Gmbh | Verfahren zur Herstellung von 3,3-Diarylpropylaminen |
| PE20020547A1 (es) | 2000-10-24 | 2002-06-12 | Upjohn Co | Uso de la tolterodina en tratamientos del asma |
| US20030027856A1 (en) * | 2001-06-29 | 2003-02-06 | Aberg A.K. Gunnar | Tolterodine metabolites |
| IN191835B (de) | 2001-08-03 | 2004-01-10 | Ranbaxy Lab Ltd | |
| ATE418534T1 (de) * | 2001-10-26 | 2009-01-15 | Pharmacia & Upjohn Co Llc | Quaternäre ammoniumverbindungen und deren verwendung als antimuscarinische wirkstoffe |
| US7005449B2 (en) * | 2002-04-23 | 2006-02-28 | Pharmacia & Upjohn Company | Tolterodine salts |
| NZ537584A (en) | 2002-07-08 | 2006-07-28 | Ranbaxy Lab Ltd | 3,6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists |
| WO2004014853A1 (en) | 2002-07-31 | 2004-02-19 | Ranbaxy Laboratories Limited | 3,6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists |
| AU2002321711A1 (en) | 2002-08-09 | 2004-02-25 | Ranbaxy Laboratories Limited | 3,6-disubstituted azabicyclo (3.1.0) hexane derivatives useful as muscarinic receptor antagonist |
| JP2006501236A (ja) | 2002-08-23 | 2006-01-12 | ランバクシー ラボラトリーズ リミテッド | ムスカリン性レセプター拮抗薬としてのフルオロおよびスルホニルアミノ含有３，６−二置換アザビシクロ（３．１．０）ヘキサン誘導体 |
| AU2003265680A1 (en) * | 2002-08-28 | 2004-03-19 | Pharmacia Corporation | Oral liquid tolterodine composition |
| US7232835B2 (en) | 2002-12-10 | 2007-06-19 | Ranbaxy Laboratories Limited | 3,6-Disubstituted azabicyclo derivatives as muscarinic receptor antagonists |
| AU2002347553A1 (en) | 2002-12-23 | 2004-07-14 | Ranbaxy Laboratories Limited | Flavaxate derivatives as muscarinic receptor antagonists |
| AU2002347552A1 (en) | 2002-12-23 | 2004-07-14 | Ranbaxy Laboratories Limited | 1-substituted-3-pyrrolidine derivatives as muscarinic receptor antagonists |
| US7488748B2 (en) | 2003-01-28 | 2009-02-10 | Ranbaxy Laboratories Limited | 3,6-Disubstituted azabicyclo hexane derivatives as muscarinic receptor antagonists |
| EP1603862A1 (de) * | 2003-03-06 | 2005-12-14 | Ranbaxy Laboratories Limited | 3,3-diarylpropylaminderivate und verfahren zu deren isolierung |
| US7393874B2 (en) * | 2003-04-08 | 2008-07-01 | Hetero Drugs Limited | Polymorphs of tolterodine tartrate |
| DE10315917A1 (de) * | 2003-04-08 | 2004-11-18 | Schwarz Pharma Ag | Hochreine Basen von 3,3-Diphenylpropylaminmonoestern |
| WO2004089898A1 (en) | 2003-04-09 | 2004-10-21 | Ranbaxy Laboratories Limited | Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists |
| AU2003223010A1 (en) | 2003-04-10 | 2004-11-01 | Ranbaxy Laboratories Limited | Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists |
| CA2521788A1 (en) | 2003-04-10 | 2004-10-21 | Ranbaxy Laboratories Limited | Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists |
| BRPI0409302A (pt) | 2003-04-11 | 2006-04-11 | Ranbaxy Lab Ltd | derivados azabiciclo como antagonistas de recetores muscarìnicos, método para sua preparação e composição farmacêutica contendo os mesmos |
| ITMI20031354A1 (it) * | 2003-07-02 | 2005-01-03 | Istituto Di Chimica Biomolecolare D El Cnr Sezione | Sintesis enantioselettiva di composti enantiomericamente arricchiti. |
| ES2235648B1 (es) * | 2003-12-22 | 2006-11-01 | Ragactives, S.L. | Procedimiento para la obtencion de tolterodina. |
| JP5250205B2 (ja) * | 2003-12-24 | 2013-07-31 | シプラ・リミテッド | トルテロジン、その組成物及び使用、及びその製造方法 |
| EP1629834A1 (de) | 2004-08-27 | 2006-03-01 | KRKA, D.D., Novo Mesto | Pharmazeutische Zusammensetzung von Tolterodin mit verzögerter Freisetzung |
| ITMI20041920A1 (it) * | 2004-10-11 | 2005-01-11 | Chemi Spa | Processo per la preparazione di n, n-diisopropil-3-2-idrossi-5-metilfenil-3-fenil-propabammina |
| US7355077B2 (en) * | 2004-10-28 | 2008-04-08 | Dr. Reddy's Laboratories Limited | Process for preparing tolterodine |
| JP4513535B2 (ja) * | 2004-12-03 | 2010-07-28 | 住友化学株式会社 | トルテロジンの製造方法 |
| JP2007527922A (ja) * | 2005-01-10 | 2007-10-04 | テバ ファーマシューティカル インダストリーズ リミティド | 実質的に純粋なトルテロジンタルトレート及びその調製方法 |
| US7528267B2 (en) * | 2005-08-01 | 2009-05-05 | Girindus America, Inc. | Method for enantioselective hydrogenation of chromenes |
| ES2268987B1 (es) * | 2005-08-05 | 2008-02-01 | Ragactives, S.L. | Procedimiento para la obtencion de 3,3-difenilpropilaminas. |
| WO2007039918A1 (en) * | 2005-10-06 | 2007-04-12 | Natco Pharma Limited | Novel process for the preparation of tolterodine |
| WO2007045979A1 (en) | 2005-10-19 | 2007-04-26 | Ranbaxy Laboratories Limited | Pharmaceutical compositions of muscarinic receptor antagonists |
| KR100686351B1 (ko) * | 2006-01-12 | 2007-02-22 | 주식회사 카이로제닉스 | 톨테로딘 라세미체의 제조방법 |
| ITMI20060110A1 (it) * | 2006-01-24 | 2007-07-25 | Dipharma Spa | Procedimento per la purificazione di tolterodina |
| CA2651978C (en) * | 2006-05-24 | 2011-06-07 | Pfizer Limited | Process for the production of benzopyran-2-ol derivatives |
| US7268257B1 (en) | 2006-05-31 | 2007-09-11 | Sumitomo Chemical Company, Limited | Process for producing tolterodine |
| CZ302585B6 (cs) * | 2007-02-26 | 2011-07-20 | Zentiva, A. S. | Krystalická sul 2-[(1R)-3-[bis(1-methylethyl)amino]-1-fenylpropyl]-4-methylfenolu s kyselinou (2R,3R)-2,3-dihydroxybutandiovou |
| US8486452B2 (en) * | 2007-07-20 | 2013-07-16 | Mylan Pharmaceuticals Inc. | Stabilized tolterodine tartrate formulations |
| US8871275B2 (en) | 2007-08-08 | 2014-10-28 | Inventia Healthcare Private Limited | Extended release compositions comprising tolterodine |
| KR101188333B1 (ko) * | 2008-02-20 | 2012-10-09 | 에스케이케미칼주식회사 | 안정성이 우수하고 경피제로 유용한 톨테로딘 결정성산부가염 |
| US20090214665A1 (en) * | 2008-02-26 | 2009-08-27 | Lai Felix S | Controlled Release Muscarinic Receptor Antagonist Formulation |
| ITMI20082055A1 (it) * | 2008-11-19 | 2009-02-18 | Dipharma Francis Srl | Procedimento per la preparazione di (r)-tolterodina base libera |
| WO2010092500A2 (en) | 2009-02-12 | 2010-08-19 | Alembic Limited | A process for the preparation of tolterodine tartrate |
| EP2398765A1 (de) * | 2009-02-17 | 2011-12-28 | Pharmathen S.A. | Verbessertes verfahren zur herstellung von (r)-2-(3-diisopropylamino-1-phenylpropyl)-4-methylphenol und salzen davon |
| EP2554184B1 (de) | 2010-03-31 | 2016-10-26 | ONO Pharmaceutical Co., Ltd. | Mittel zur verhinderung und/oder heilung des hand-fuss-syndroms |
| WO2012098044A1 (en) | 2011-01-17 | 2012-07-26 | Cambrex Profarmaco Milano S.R.L. | Process for the preparation of n,n-diisopropyl-3-(2-hydroxy-5-methylphenyl)- 3-phenyl propylamine and its salts starting from a novel intermediate |
| EP2476665A1 (de) | 2011-01-17 | 2012-07-18 | Cambrex Profarmaco Milano S.r.l. | Verfahren zur Herstellung von N,N-diisopropyl-3-(2-hydroxy-5-methylphenyl)- 3-phenyl-Propylamin und seine Salze aus einem neuartigen Zwischenstoffs |
| CN102516098B (zh) * | 2011-12-09 | 2014-06-18 | 北京联本医药化学技术有限公司 | 酒石酸托特罗定制备方法 |
| CN103044274B (zh) * | 2012-11-29 | 2014-10-22 | 珠海保税区丽珠合成制药有限公司 | 一种无溶剂合成酒石酸托特罗定的方法 |
| GB201402556D0 (en) | 2014-02-13 | 2014-04-02 | Crystec Ltd | Improvements relating to inhalable particles |
| CN110229072B (zh) * | 2019-06-25 | 2022-04-08 | 中国药科大学 | 一种托特罗定及其对映体的合成方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1169945A (en) * | 1966-08-25 | 1969-11-05 | Geistlich Soehne Ag | Pharmaceutical Compositions containing Diphenylalkyl-amine Derivatives |
| US5382600A (en) * | 1988-01-22 | 1995-01-17 | Pharmacia Aktiebolag | 3,3-diphenylpropylamines and pharmaceutical compositions thereof |
| SE8800207D0 (sv) * | 1988-01-22 | 1988-01-22 | Kabivitrum Ab | Nya aminer, deras anvendning och framstellning |
| ATE161530T1 (de) * | 1992-09-04 | 1998-01-15 | Takeda Chemical Industries Ltd | Kondensierte heterozyklische verbindungen, deren herstellung und verwendung |
| RU2089539C1 (ru) * | 1994-04-05 | 1997-09-10 | Стерлитамакский нефтехимических завод | Способ получения 2,5-n,n'-(диметиламинометил)-1,4-гидрохинона |
-
1997
- 1997-11-21 KR KR1019990705269A patent/KR20000057548A/ko not_active Withdrawn
- 1997-12-18 AT AT97954678T patent/ATE226949T1/de active
- 1997-12-18 FI FI991477A patent/FI991477A0/fi unknown
- 1997-12-18 RU RU99116356/04A patent/RU2176246C2/ru not_active IP Right Cessation
- 1997-12-18 EP EP97954678A patent/EP0960109B1/de not_active Expired - Lifetime
- 1997-12-18 SI SI9730426T patent/SI0960109T1/xx unknown
- 1997-12-18 CA CA002273789A patent/CA2273789C/en not_active Expired - Fee Related
- 1997-12-18 US US08/993,257 patent/US5922914A/en not_active Expired - Lifetime
- 1997-12-18 KR KR10-1999-7005910A patent/KR100463614B1/ko not_active Expired - Fee Related
- 1997-12-18 DE DE69716767T patent/DE69716767T2/de not_active Expired - Lifetime
- 1997-12-18 JP JP53003098A patent/JP4199310B2/ja not_active Expired - Fee Related
- 1997-12-18 DK DK97954678T patent/DK0960109T3/da active
- 1997-12-18 CZ CZ19992272A patent/CZ295477B6/cs not_active IP Right Cessation
- 1997-12-18 WO PCT/US1997/022521 patent/WO1998029402A1/en not_active Ceased
- 1997-12-18 CN CNB971801479A patent/CN1151141C/zh not_active Expired - Fee Related
- 1997-12-18 ES ES97954678T patent/ES2186018T3/es not_active Expired - Lifetime
- 1997-12-18 PT PT97954678T patent/PT960109E/pt unknown
- 1997-12-18 PL PL334375A patent/PL191603B1/pl not_active IP Right Cessation
- 1997-12-18 NZ NZ336533A patent/NZ336533A/xx not_active IP Right Cessation
- 1997-12-18 HU HU0000527A patent/HUP0000527A3/hu unknown
- 1997-12-18 AU AU59569/98A patent/AU717985B2/en not_active Ceased
- 1997-12-18 SK SK815-99A patent/SK283591B6/sk not_active IP Right Cessation
-
1999
- 1999-06-29 NO NO19993247A patent/NO317158B1/no not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI991477A7 (fi) | Menetelmä tolterodiinin valmistamiseksi | |
| FI965268L (fi) | Menetelmä moniarvoisten alkoholien valmistamiseksi | |
| FI951780L (fi) | Menetelmä katalyyttikomponenttien valmistamiseksi | |
| FI954498A7 (fi) | Menetelmä persuolahiukkasten valmistamiseksi | |
| FI956237A7 (fi) | Menetelmä aromaattisten olefiinien valmistamiseksi | |
| FI971175A7 (fi) | Menetelmä polytetrahydrofuraanin valmistamiseksi | |
| FI962069L (fi) | Menetelmä karpolaktaamin valmistamiseksi | |
| KR970001365A (ko) | 알킬하이드로겐클로로실란의 제조방법 | |
| FI20050181L (fi) | Menetelmä valmistaa 21-kloorikortikosteroideja | |
| FI952484L (fi) | Menetelmä metallihydroksidien valmistamiseksi | |
| EE9800240A (et) | Meetod fermenteeritava virde valmistamiseks | |
| FI972720A0 (fi) | Menetelmä lamotrigiinin valmistamiseksi | |
| FI955800L (fi) | Menetelmä aminoalkyyliganidiinien valmistamiseksi | |
| FI964001L (fi) | Menetelmä 7-trialkyylisilyylibakkatiini III:n valmistamiseksi | |
| FI963452L (fi) | Menetelmä epoxidin valmistamiseksi | |
| FI972065L (fi) | Menetelmä N-fosfonometyyliglysiinin valmistamiseksi | |
| BR9703095A (pt) | Processo para preparação de aldeídos | |
| FI972314L (fi) | Menetelmä kaprolaktaamin valmistamiseksi | |
| FI956233A7 (fi) | Menetelmä aldehydien valmistamiseksi | |
| FI963018L (fi) | Menetelmä gammapyronien valmistamiseksi | |
| FI972719A7 (fi) | Menetelmä lamotrigiinin valmistamiseksi | |
| FI962967A7 (fi) | Menetelmä aerosolin valmistamiseksi | |
| ZA989228B (en) | Method for preparing substituted 4-phenyl-4-cyanocyclo-hexanoic acids | |
| FI964410L (fi) | Menetelmä 4-amino-delta4-3-ketosteroidien valmistamiseksi 4-nitro-delta4-3-ketosteroidien kautta | |
| FI964002A7 (fi) | Menetelmä 7-hydroksitaksaanien valmistamiseksi |